A Lifeline for Those Affected HIV, or human immunodeficiency virus, remains a critical public health issue, impacting millions globally. Despite advancements in medical science, the stigma surrounding ...
The major HIV and AIDS health agencies in France, Haute Autorité de Santé (HAS), the National Agency for Research on HIV/AIDS and Emerging Infectious Diseases (ANRS MIE), and the National Council on ...
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 4.4% year on year to $6.96 billion. The company expects the ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new research data from its innovative HIV treatment portfolio and pipeline, including a ...
A newly approved prevention treatment for HIV will soon hit the market for Minnesotans, despite recent cuts to public health agencies spearheaded by the U.S. Health and Human Services Department.
LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of abstracts from its ...
Penobscot County is grappling with Maine’s largest HIV outbreak in its history. Looking back, the top public health official for the county seat of Bangor described how the conditions existed for such ...